Skip to content

MINDMAP-Study: Mechanisms of change during Psychotherapy: a multidimensional approach

MINDMAP-Study: Mechanisms of change during Psychotherapy: a multidimensional approach - MINDMAP-Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031723
Enrollment
300
Registered
2023-04-24
Start date
2023-06-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychiatric disorders, especially anxiety disorders, depressive disorders, eating disorders, somatic symptom disorder

Interventions

Group 1: Patients in inpatient or day clinic treatment will be asked about their psychological well-being (see endpoints) during their treatment (6-12 weeks) and after that (total of 40 weeks). In add

Sponsors

Klinik für Psychosomatik und Psychotherapie des UKSH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - sufficient German language skills - willingness to work on relevant behavior patterns during intensive psychotherapy - written informed consent

Exclusion criteria

Exclusion criteria: 1) acute suicidality requiring safe ward inpatient treatment 2) known life time diagnosis of organic, including symptomatic psychiatric disorder 3) known life time diagnosis of major psychotic disorder 4) known acute substance use disorder (alcohol, cannabis, sedative, cocaine hallucinogen) requiring detoxification 5) known life time diagnosis of bipolar disorder (type I) 6) known diagnosis of a somatic disorder requiring and inpatient treatment in a somatic hospital

Design outcomes

Primary

MeasureTime frame
Health related life satisfaction measured by self-rating questionnaire Short-Form-Health-Survey-12 (SF-12) particularly subscale mental health during inpatient or day clinic treatment and in the follow-up phase over 40 weeks (T0-T11).

Secondary

MeasureTime frame
Additional questionnaires assessing general anxiety using the Generalized Anxiety Disorder-7 (GAD-7), somatic symptoms using the Somatic Symptoms Disorder – B Criteria Scale-12, symptoms of eating disorder using the eating disorder examination questionnaire-8 (EDE-Q8) and depressiv symptoms using the Patient Health Questionnaire (PHQ-9) at (T0), T2, T4, T6, T8-11. T4 includes a questionnaire asking for the satisfaction with the treatment (Client Satisfaction Questionnaire, CSQ-8).

Countries

Germany

Contacts

Public ContactNele Assmann

Klinik für Psychiatrie und Psychotherapie des UKSH

nele.assmann@uksh.de+49 451 500 98758

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026